MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202411025463 A) filed by Athena Pharmaceutiques Sas, Louveciennes, France, on March 28, 2024, for 'lisdexamfet... Read More
MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202411025454 A) filed by Chandigarh University; and Chandigarh University Technology Business Incubator, Mohal... Read More
MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202411025450 A) filed by Chandigarh University; and Chandigarh University Technology Business Incubator, Mohal... Read More
MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202411025449 A) filed by Chandigarh University; and Chandigarh University Technology Business Incubator, Mohal... Read More
MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202411025488 A) filed by Chandigarh Group Of Colleges, Mohali, Punjab, on March 28, 2024, for 'automated anti-... Read More
U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07227922) titled 'Clofutriben Pharmacokinetics in Patients With Impaired Renal Function' on Nov. 06. Brief S... Read More
U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07227961) titled 'PROMIS and Mobility Evaluation in Sarcoma Patients' on Nov. 04. Brief Summary: The goal of... Read More
U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07227831) titled 'A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer'... Read More
U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07227818) titled 'Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia' on Nov. 11. Br... Read More
U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07227896) titled 'Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Pa... Read More